These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6276710)

  • 1. Structural requirements for specific recognition of mu or delta opiate receptors.
    Fournie-Zaluski MC; Gacel G; Maigret B; Premilat S; Roques BP
    Mol Pharmacol; 1981 Nov; 20(3):484-91. PubMed ID: 6276710
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
    Shimohigashi Y; Costa T; Matsuura S; Chen HC; Rodbard D
    Mol Pharmacol; 1982 May; 21(3):558-63. PubMed ID: 6287194
    [No Abstract]   [Full Text] [Related]  

  • 4. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
    Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selectivity of [D-Ala2-O-benzyl-Ser5]-enkephalin on mu and delta opiate receptor subtypes].
    Ji XQ; Zhang HL; Liu S; Zou G
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):3-5. PubMed ID: 2986407
    [No Abstract]   [Full Text] [Related]  

  • 6. A multiplicity of opiate receptors and enkephalin neuronal systems.
    Snyder SH
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):9-12. PubMed ID: 6282818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design principles: enkephalins with predictable mu/delta receptor specificity.
    Shimohigashi Y
    NIDA Res Monogr; 1986; 69():65-100. PubMed ID: 3020418
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol?
    Rapaka RS; Bhargava HN; Renugopalakrishnan V; Collins BJ
    NIDA Res Monogr; 1986; 75():355-8. PubMed ID: 2828985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydro-enkephalins. VI. Dehydroalanine3-enkephalin: a potent enkephalin analog for the delta opiate receptor.
    Shimohigashi Y; Stammer CH
    Int J Pept Protein Res; 1982 Sep; 20(3):199-206. PubMed ID: 6290409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
    Kondo M; Kodama H; Costa T; Shimohigashi Y
    Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat.
    Bhargava HN; Gulati A
    NIDA Res Monogr; 1990; 105():530-1. PubMed ID: 1652091
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of calcium-channel blockers (CCB) on mu and delta opioid receptors in rat brain membranes.
    Schwarz S; Katki AG
    Prog Clin Biol Res; 1990; 328():109-12. PubMed ID: 2154761
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of mu- and delta-opiate receptors in the realization of the autonomic effects of opioid peptides].
    Martynova ER; Medvedev OS
    Biull Eksp Biol Med; 1986 Jan; 101(1):60-3. PubMed ID: 3002521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum.
    Crema G; Gioannini TL; Hiller JM; Simon EJ
    NIDA Res Monogr; 1986; 75():9-12. PubMed ID: 2829015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding selectivity of short [D-Arg2,Leu5]enkephalin analogues to mu- and delta-subclasses of opiate receptors.
    Rosenthal GF; Inkina NM; Abissova NA; Bobrova IV; Chipens GI
    Biomed Sci; 1990 Apr; 1(4):414-6. PubMed ID: 1966782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active conformation of [Met5]- and [Leu5]enkephalin on delta opioid receptor.
    Gasparík J
    Eur J Pharmacol; 1989 Dec; 172(6):417-23. PubMed ID: 2558897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.